Plain-English translation of NCT02886247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The National Familial Pancreas Tumor Registry is a long-running study that has been collecting information from pancreatic cancer patients and their families since 1994. Researchers want to understand both genetic and non-genetic reasons why pancreatic cancer develops, and especially why it sometimes clusters in certain families. By joining this registry, you help scientists identify genes and other factors that may explain familial pancreatic cancer.
About one in ten pancreatic cancer patients has a close relative who also had the disease, but we don't fully understand why. Researchers have already discovered that mutations in certain genes like PALB2 and ATM account for some of this familial clustering, but there's much more to learn. This registry exists to find additional genes and factors that could help predict risk and improve prevention and treatment strategies for families affected by pancreatic cancer.
You likely qualify if…
You likely don't qualify if…
Participation in this registry typically involves sharing your personal and family medical history, including any diagnoses of pancreatic cancer or related conditions. You may be asked to provide information about your relatives and possibly provide a blood or tissue sample for genetic testing. The study is ongoing and designed to accommodate participants at different points in their cancer journey, whether newly diagnosed or years after treatment.
AI-generated summary from trial data · Aug 10, 2026 · Not medical advice
United States